Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Soltysiak

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Experimental Hematology|September 23, 2022
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaFaezeh Darbaniyan, Hong Zheng, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 31, 2021
Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Faezeh Darbaniyan, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology|September 4, 2020
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3)Koji Sasaki, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2023
Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End ResultsKoji Sasaki, Kiyomi Morita, Hagop Kantarjian, et al.
Cancer|June 23, 2021
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromesRashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Koji Sasaki, et al.
Cancer|March 13, 2019
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndromeKiran Naqvi, Koji Sasaki, Guillermo Montalban-Bravo, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.
American Journal of Hematology|November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomesKoji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Blood Advances|February 7, 2020
Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromesGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Christopher B Benton, et al.
British Journal of Haematology|August 2, 2021
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndromeKelly S Chien, Kunhwa Kim, Graciela M Nogueras-Gonzalez, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Experimental Hematology|September 23, 2022
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaFaezeh Darbaniyan, Hong Zheng, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 31, 2021
Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Faezeh Darbaniyan, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology|September 4, 2020
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3)Koji Sasaki, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2023
Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End ResultsKoji Sasaki, Kiyomi Morita, Hagop Kantarjian, et al.
Cancer|June 23, 2021
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromesRashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Koji Sasaki, et al.
Cancer|March 13, 2019
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndromeKiran Naqvi, Koji Sasaki, Guillermo Montalban-Bravo, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.
American Journal of Hematology|November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomesKoji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Blood Advances|February 7, 2020
Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromesGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Christopher B Benton, et al.
British Journal of Haematology|August 2, 2021
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndromeKelly S Chien, Kunhwa Kim, Graciela M Nogueras-Gonzalez, et al.
Pageof 5